Amniotic Membrane Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Report Covers Amniotic Membrane Market Growth and it is segmented by Enzyme (Cryopreserved Amniotic Membrane and Dehydrated Amniotic Membrane), Application (Ophthalmology, Surgical Wounds, and Other Applications), End-User (Hospitals, Ambulatory Surgical Centers, and Other End-Users), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The Market values are Provided (in USD million) for the above segments.

Amniotic Membrane Market Size

Amniotic Membrane Market Summary
Study Period 2019 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
CAGR 11.10 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

Amniotic Membrane Market Major Players

*Disclaimer: Major Players sorted in no particular order


Need a report that reflects how COVID-19 has impacted this market and its growth?

Amniotic Membrane Market Analysis

The amniotic membrane market is expected to register a CAGR of 11.1% over the forecast period.

  • The outbreak of the COVID-19 pandemic impacted the amniotic membrane market initially. Most elective surgeries were suspended globally to mitigate the spread of COVID-19 infection. Due to delayed surgeries and the closure of elective procedures, most of the end-users witnessed the expiry of their stock of amniotic membranes coinciding with the COVID-19 outbreak, which adversely impacted the market. However, the growth of the market studied was balanced by the increasing need for surgeries and ophthalmic procedures accompanied by increased childbirth globally.
  • An article, 'Amniotic membrane harvesting during COVID-19 pandemic,' published in March 2021, suggested that whether amniotic membranes from infected donors carry COVID-19 is unknown, and the probability of vertical transmission is low risk and not definite. Hence, followed by several research studies, the usage of amniotic membranes significantly increased in ophthalmic centers. Thus, the COVID-19 pandemic is anticipated to have a positive impact on the market studied.
  • Factors such as a rise in the number of accident and trauma cases, increasing awareness about the benefits offered by an amniotic membrane, and rising research on stem cell biology and regenerative medicine are the major driving factors for the studied market growth. Additionally, the growing number of surgeries performed and rising expenditure on research and development (R&D) in the field of stem cells and regenerative medicine are also some of the key factors driving the overall market.
  • For instance, as per the data published by the United States Department of Labor in December 2022, over 5,190 fatal work injuries were reported in the United States in 2021, which increased from 4,764 cases compared to 2020. Burn injuries represent a significant disease burden on the world population, with nearly 9 million injuries and an estimated 120,000-180,000 deaths annually, as mentioned in the research paper 'Burn injury prevention in low- and middle- income countries (LMICs): scoping systematic review' published in October 2021. According to the above-mentioned research, almost 18 million disability-adjusted life years (DALYs) can be accounted for burns, with a disproportionate 90% of this burden which is borne by LMICs. Also, in Bangladesh, Colombia, Egypt, and Pakistan, burn injuries account for up to 18% of permanent disabilities, as per the same research above. The amniotic membrane is commonly used to treat up to second-degree burn wounds. Thus, the rising burden of burn injuries globally is expected to create a high demand for the amniotic membrane for the purpose of tissue repair and regeneration, and it is expected to boost the market growth over the forecast period.
  • The market studied consists of several major players, and their strategic product innovation is garnering market growth. For instance, in August 2021, Vivex Biologics, Inc., a leading regenerative medicine company, launched Cygnus Matrix Disks, which is the latest configuration from the Cygnus family of amniotic tissue allografts. Thus, the continuous innovation in the amniotic membrane segment is expected to drive the overall growth of the market studied.
  • Therefore, owing to the aforementioned factors, it is anticipated that the studied market will witness growth over the analysis period. However, the lack of standardized guidelines and skilled professionals will likely impede market growth.

Amniotic Membrane Market Trends

Surgical Wounds Segment is Expected to Grow Significantly Over the Forecast Period

  • Amniotic membrane has several antimicrobial and biological properties in corneal surgery, as it enhances epithelialization, reinforces adhesion of basal epithelial cells, maintains epithelial phenotype, and modulates the proliferation of normal corneal, conjunctival, and limbal fibroblast. These membranes also prevent apoptosis as well as inhibit scarring, inflammation, and neovascularization. Several research studies have underlined the diverse applications of amniotic membranes for the surgical treatment of various wounds. For instance, a study published in the journal Membrane in June 2021 highlighted the vast potential of the human amniotic membrane in tissue engineering and tissue regeneration and has shown desirable results in vascular, bone repair, cartilage repair, and oral surgery.
  • Furthermore, the key developments by the market players are expected to boost the growth of the segment. For instance, in October 2022, the hydrated human amnion membrane allograft product by BioLab Sciences, Membrane Wrap - Hydro, was recognized by the United States Food and Drug Administration (US FDA) Tissue Reference Group (TRG) as a human cell, tissue/ cellular/tissue-based product (HCT/P). The product is indicated for the management of surgical wounds and other wounds. Such recognition by the USFDA would enable the product to be easily reimbursed by the insurance bodies, which would make the product very affordable and in high demand.
  • In September 2022, MiMedx Group, Inc. launched its Amnioeffect, a tri-layer Purion processed human tissue allograft, which consists of the chorion, amnion, and intermediate membrane layers of the placenta. The products offer suitable healing of the surgical wound. The company stated that the product launch would expand its surgical recovery product portfolio. Such developments would create more opportunities for the amniotic membrane to be used in the management of surgical wounds, which would be able to meet the high demand for surgical wound healing.
  • Therefore, owing to the factors stated above, the surgical wounds segment is growing, and it is expected to have significant growth over the forecast period. Hence driving the growth of the studied market.
Amniotic Membrane Market - Fatalities per 100 Million, Vehicle Miles Traveled (VMT) In The First 9 Months of 2019- 2022, the United States

North America is Expected to Grow Significantly Over the Forecast Period

  • North America is the largest regional market in terms of revenue, owing to high healthcare expenditure, highly developed healthcare infrastructure, and the recent developments by the market players. For instance, according to the data published by the United States Centers for Medicare & Medicaid Services in February 2023, the national healthcare expenditure has increased by 2.7% to USD 4.3 trillion in 2021 compared to 2020.
  • The same source also stated that Medicare and Medicaid expenditures increased by 8.4% to USD 900.8 billion in 2021 and 9.2% to USD 734.0 billion, respectively, in 2021 as compared to 2020. The increase in reimbursement of medical products will make medical care products more affordable, and it will enable more patients to adopt medical care, including amniotic membrane products, which will boost the market growth in the region.
  • Furthermore, the key developments by market players are anticipated to boost market growth in the North American region. For instance, in March 2021, TissueTech received clearance from the Food and Drug Administration (FDA) to proceed with a Phase 2 study using morselized Cryopreserved Amniotic Membrane (CAM) and Cryopreserved Umbilical Cord (CUC) Investigational New Drug (IND) TTBT01.
  • Again, in May 2021, Vivex Biologics, Inc., a leading regenerative medicine company specializing in the development of naturally sourced treatments, launched Viagenex, which is a family of amniotic allografts are processed to retain the inherent mechanical properties of amniotic tissue and rich supply of extracellular matrix, growth factors, and cytokines. Thus, the rigorous product development in countries across North America is expected to boost the amniotic membrane market growth in the region.
  • Therefore, owing to the aforementioned factors, the growth of the studied market is anticipated in the North America Region.
Amniotic Membrane Market - Growth Rate By Region

Amniotic Membrane Industry Overview

The amniotic membrane market is moderately competitive in nature due to the presence of a few companies operating globally as well as regionally. The competitive landscape includes an analysis of some international as well as local companies that hold market shares and are well known, including Human Regenerative Technologies, LLC, Katena Products. Inc., Mimdex, Amnio Technology, LLC, TissueTech, Inc. (BioTissue). Integra LifeSciences Corporation, Skye Biologics Inc., Amniox Medical Inc., Laboratoire CCD, Vivex Biologics, Inc., Merakris Therapeutics, and Akorn Operating Company LLC, among others.

Amniotic Membrane Market Leaders

  1. Human Regenerative Technologies, LLC

  2. Katena Products. Inc.


  4. Amnio Technology, LLC

  5. TissueTech, Inc. (BioTissue)

*Disclaimer: Major Players sorted in no particular order

Amniotic Membrane Market Concentration
Need More Details on Market Players and Competitors?
Download PDF

Amniotic Membrane Market News

  • February 2022: Amnio Technology, a global leader in the development of and distribution of amniotic tissue allografts, launched two new palingen membrane products, palingen dual-layer membrane and dual-layer palingen x-membrane. The new allografts, like the entire family of PalinGen membrane products, are minimally manipulated, homologous use, and chorion-free. The palingen dual-layer membrane and dual-layer palinGen X-membrane are indicated for patients suffering from non-healing acute and chronic wounds as well as complex and/or open surgical wounds and burns.
  • January 2022: Laboratoires Thea SAS, one of the leading independent pharmaceutical companies in Europe, signed an agreement to purchase seven branded ophthalmic products from Akorn Operating Company LLC, including AcellFX (acellular amniotic membrane), which provides a protective environment or covering for repair to the ocular surface.

Amniotic Membrane Market Report - Table of Contents


    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rise in the Number of Accident and Trauma Cases

      2. 4.2.2 Increasing Awareness about the Benefits Offered by Amniotic Membrane

      3. 4.2.3 Rising Research on Stem Cell Biology and Regenerative Medicine

    3. 4.3 Market Restraints

      1. 4.3.1 Lack of Standardized Guidelines and Skilled Professionals

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 5.1 By Enzyme

      1. 5.1.1 Cryopreserved Amniotic Membrane

      2. 5.1.2 Dehydrated Amniotic Membrane

    2. 5.2 By Application

      1. 5.2.1 Ophthalmology

      2. 5.2.2 Surgical Wounds

      3. 5.2.3 Other Applications

    3. 5.3 By End-User

      1. 5.3.1 Hospitals

      2. 5.3.2 Ambulatory Surgical Centers

      3. 5.3.3 Other End-Users

    4. 5.4 Geography

      1. 5.4.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.4.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.4.4 Middle East and Africa

        1. GCC

        2. South Africa

        3. Rest of Middle East and Africa

      5. 5.4.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 Amnio Technology, LLC

      2. 6.1.2 TissueTech, Inc. (BioTissue)

      3. 6.1.3 Human Regenerative Technologies, LLC

      4. 6.1.4 Katena Products. Inc.

      5. 6.1.5 MIMEDX

      6. 6.1.6 Integra LifeSciences Corporation

      7. 6.1.7 Skye Biologics Inc.

      8. 6.1.8 Amniox Medical Inc.

      9. 6.1.9 Laboratoire CCD

      10. 6.1.10 VIVEX Biologics, Inc.

      11. 6.1.11 Merakris Therapeutics

      12. 6.1.12 Thea Pharma

    2. *List Not Exhaustive

**Subject to Availability
Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Amniotic Membrane Industry Segmentation

The amniotic membrane consists of a combination of tissues and cells, and it is the innermost layer of the placenta, which is widely used in ophthalmology and wound healing. 

The amniotic membrane market is segmented by enzyme (cryopreserved amniotic membrane and dehydrated amniotic membrane), application (ophthalmology, surgical wounds, and other applications), end-user (hospitals, ambulatory surgical centers, and other end-users), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. 

The report offers the value (in USD ) for the above segments.

By Enzyme
Cryopreserved Amniotic Membrane
Dehydrated Amniotic Membrane
By Application
Surgical Wounds
Other Applications
By End-User
Ambulatory Surgical Centers
Other End-Users
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle East and Africa
South Africa
Rest of Middle East and Africa
South America
Rest of South America
Need A Different Region Or Segment?
Customize Now

Amniotic Membrane Market Research FAQs

The Global Amniotic Membrane Market is projected to register a CAGR of 11.10% during the forecast period (2024-2029)

Human Regenerative Technologies, LLC, Katena Products. Inc., MIMEDX, Amnio Technology, LLC and TissueTech, Inc. (BioTissue) are the major companies operating in the Global Amniotic Membrane Market.

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).

In 2024, the North America accounts for the largest market share in Global Amniotic Membrane Market.

The report covers the Global Amniotic Membrane Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Amniotic Membrane Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.

Amniotic Membrane Industry Report

Statistics for the 2023 Amniotic Membrane market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Amniotic Membrane analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!

Amniotic Membrane Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)